health_en | Page 52 of 128

Apollo Proton Cancer Centre successfully performs Asia’s 1st Brain Bypass Surgery on twin children with Moya Moya Disease

Apollo Proton Cancer Centre (APCC) recently performed Asia’s first brain bypass surgery on twin 8-year-old children from the Netherlands. The integration of advanced technology and expertise at APCC helped the children to undergo surgery and recover quickly. The first case to be witnessed in Asia of Moya Moya disease — a rare blood vessel (vascular) disorder in which […]

8 ธ.ค. 65 8:002022-12-08

thaipr.net

8 ธ.ค. 65

Sirolimus Coated Balloon in BTK Treatment makes a bold presence at VEITH 2022 – Lights up NY Times Square, NASDAQ

VEITH 2022 witnessed a surge of supporting clinical data for Sirolimus Coated Balloon in the treatment of Below-the-Knee (BTK) disease. Concept Medical Inc. hosted a lunch symposium titled ‘Sirolimus Coated Balloon in PAD Treatment: Choice of The Future’ which explored the utility of Sirolimus Coated Balloon treatment in PAD. The session was chaired by Prof. Sahil […]

7 ธ.ค. 65 8:00

thaipr.net

7 ธ.ค. 65

FOUNDATION FOR ANGELMAN SYNDROME THERAPEUTICS (FAST) ANNOUNCES $5 MILLION GIFT TO ADVANCE CLINICAL TRIALS IN RARE NEURODEVELOPMENTAL DISORDERS

The Center at Rush University Will Be Directed By Dr. Elizabeth Berry-Kravis The Foundation for Angelman Syndrome Therapeutics (FAST) announced today a $5 million gift to establish the new clinical trial and translational research effort for rare neurodevelopmental disorders, a first-of-its-kind flagship center to be directed by Dr. Elizabeth Berry-Kravis. Named the Rush F.A.S.T. Center […]

6 ธ.ค. 65 8:15

thaipr.net

6 ธ.ค. 65

Menarini Group Presents Updated Results from Pivotal Phase 3 EMERALD Trial at the 2022 San Antonio Breast Cancer Symposium (SABCS) that Demonstrate Elacestrant’s PFS Increases with Duration of Prior CDK4/6i in ER+, HER2- in Metastatic Setting

Elacestrant demonstrated longer progression-free survival (PFS) vs SOC endocrine therapy with medians up to 8.6 months, positively associated with the duration of prior treatment with CDK4/6 inhibitors Elacestrant side effects were manageable and consistent with previously reported results Results demonstrate that elacestrant may have the potential to become a new standard of care as a monotherapy endocrine sequencing […]

6 ธ.ค. 65 8:00

thaipr.net

6 ธ.ค. 65

Encore Medical Education announces publication of the Official Best of SABCS® News Highlights summarizing key trial results from the 2022 SABCS®

Best of SABCS® News Highlights coverage will provide daily expert video summaries along with original presentation slides of the most significant breast cancer trials for oncologists worldwide. Encore Medical Education, a US-based medical education company will launch the 2022 edition of the Best of SABCS® News Highlights program from the 2022 San Antonio Breast Cancer Symposium (SABCS®) starting December […]

2 ธ.ค. 65 11:58

thaipr.net

2 ธ.ค. 65

Pfizer Thailand receives Platinum Level Award at AMCHAM CSR Excellence Recognition Award 2022

Pfizer Thailand recently received an AMCHAM CSR Excellence Recognition Award at the Platinum Level as recognition for its continued commitment and contribution toward CSR in support of the health and…

1 ธ.ค. 65 11:10

thaipr.net

1 ธ.ค. 65

Bumrungrad launches the Neurocritical Care Unit (NCCU), strengthening our ICU capabilities to treat life-threatening and critically-ill neurological patients.

The WHO states there are hundred kinds of neurologic diseases, one of the most common diseases is stroke, which is the second leading cause of death and the third leading cause of disability.…

1 ธ.ค. 65 10:412022-12-01

thaipr.net

1 ธ.ค. 65

LUCIDITY phase 3 topline data presented at CTAD for HMTM – the only oral anti-Tau therapy in late-stage development

– Tau aggregation inhibitor, HMTM, is an oral drug with a strong safety profile, having no risk of amyloid related imaging abnormalities – Topline results for the Phase 3 study, LUCIDITY, were shared at the Clinical Trials in Alzheimer’s Disease (CTAD) conference on Wednesday, 30th November 2022, in San Francisco – For people with early […]

1 ธ.ค. 65 8:45

thaipr.net

1 ธ.ค. 65

Global alliance of heart patient organizations unveils new Global Cholesterol Action Plan to prioritize unhealthy cholesterol as a main public health issue

The Global Heart Hub has today launched its Global Cholesterol Action Plan to reduce the impact of unhealthy cholesterol levels . Presented at their annual UNITE Summit , the Action Plan follows and builds upon the World Heart Federation’s Cholesterol Roadmap released in October. Atherosclerotic cardiovascular disease (ASCVD) accounts for 85% of all cardiovascular-related deaths and is the leading cause of […]

30 พ.ย. 65 15:10

thaipr.net

30 พ.ย. 65

Probiotic strain SNZ 1969® helps manage IBS-D & IBS-C symptoms effectively, latest clinical study shows

Latest study shows Sanzyme Biologics’s Bacillus coagulans SNZ 1969® (Weizmannia coagulans SNZ 1969), a natural spore forming probiotic strain over five decades of use and more than 30 human studies across age groups found to be effective in managing IBS symptoms. This study is unique as it covers both the IBS-Diarrhea and IBS-Constipation groups with larger number of subjects. […]

30 พ.ย. 65 8:05

thaipr.net

30 พ.ย. 65